NCT02624752.

Trial name or title	Oral nutrition supplementation in hospitalized patients (NutriSuP Oral)
Methods	Randomised clinical trial, Switzerland
Participants	Hospitalised adults admitted to a general medical ward and recruited within 48 hours, over the age of 65 years, and malnourished (subjective global assessment categories B or C patients), at nutritional risk according to a screening tool. Expected number: 60 participants Exclusion criteria: have an allergy or intolerance to any component of the oral supplement, are designated palliative care, are currently suffering from refeeding syndrome, have a pre‐existing medical condition that prevents oral intake of full fluids, or a contraindication to administration of fluid (i.e. are in volume overloaded state, are being given IV furosemide, or have end‐stage renal disease requiring renal replacement therapy with haemodialysis or peritoneal dialysis), have a diagnosis or suspicion of septic shock, have an expected length of stay of < 48 hours from the time of assessment, have suspected ischaemic stroke as cause for admission, reside in a residential care home, are unable to walk prior to current illness, are pregnant/breastfeeding, have a current diagnosis of diabetic ketoacidosis or hyperglycemic hyperosmolar syndrome
Interventions	Experimental group: 2 cans of Ensure (or similar product) a day while in hospital and will continue 2 cans a day of Ensure when discharged home until they have been receiving the enhanced ONS for a total of 90 days Control group: No intervention Co‐intervention: Standard care
Outcomes	Readmission rate, adherence to treatment
Starting date	December 4th 2015
Contact information	stephanie.handsor@lhsc.on.ca
Notes	Status: not yet recruiting NCT02624752